Geode Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
59,553
+559
| +0.9% | +$26.4K | ﹤0.01% | 3025 |
|
|
2025
Q1 | $2.3M | Buy |
58,994
+44
| +0.1% | +$1.72K | ﹤0.01% | 2984 |
|
|
2024
Q4 | $3.19M | Buy |
58,950
+540
| +0.9% | +$29.2K | ﹤0.01% | 2955 |
|
|
2024
Q3 | $2.95M | Sell |
58,410
-90
| -0.2% | -$4.54K | ﹤0.01% | 3004 |
|
|
2024
Q2 | $2.57M | Buy |
58,500
+4,474
| +8% | +$197K | ﹤0.01% | 3046 |
|
|
2024
Q1 | $2.71M | Buy |
54,026
+5,252
| +11% | +$264K | ﹤0.01% | 2995 |
|
|
2023
Q4 | $2.95M | Buy |
48,774
+4,966
| +11% | +$300K | ﹤0.01% | 2962 |
|
|
2023
Q3 | $2.5M | Buy |
43,808
+11,840
| +37% | +$675K | ﹤0.01% | 2992 |
|
|
2023
Q2 | $1.63M | Buy |
31,968
+14,859
| +87% | +$758K | ﹤0.01% | 3175 |
|
|
2023
Q1 | $366K | Buy |
17,109
+5,658
| +49% | +$121K | ﹤0.01% | 3774 |
|
|
2022
Q4 | $120K | Buy |
+11,451
| New | +$120K | ﹤0.01% | 4327 |
|